促销!

FOXO4

原价为:$330.00。当前价格为:$323.00。

+ Free Shipping
SKU: N/A 分类:

FOXO4-DRI (Proxofim)

⚠️ Disclaimer: For Research Use Only. Not for human administration or clinical therapy.

Basic Information

  • CAS No.: 2460055-10-9
  • Alias: FOXO4, FOXO4 D-Retro-Inverso peptide, Proxofim
  • Sequence (1-letter D-amino acid): H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
  • Molecular Formula: \(\boldsymbol{C_{228}H_{388}N_{86}O_{64}}\)
  • Molecular Weight: 5358.05 g/mol
  • Appearance: White to off-white lyophilized powder
  • Solubility: Soluble in bacteriostatic water / sterile water
  • Storage: Lyophilized powder stored at -20℃, protected from light and moisture. Avoid repeated freeze-thaw cycles. After reconstitution, refrigerate and use promptly.

Development Background

FOXO4-DRI (Proxofim) is a synthetic D-retro-inverso peptide developed by researchers at Erasmus University Medical Center Rotterdam, first published in Cell (2017). It is rationally designed based on the FOXO4 forkhead domain protein sequence. The retro-inverso design uses reversed sequence + D-amino acids, which mimics the 3D binding surface of native FOXO4 while making the peptide highly resistant to protease degradation. It also carries a cell-penetrating TAT domain for intracellular delivery.

Mechanism of Action (Research Findings)

  • Competes with endogenous FOXO4 protein to disrupt the FOXO4–p53 protein-protein interaction inside senescent cells.
  • In senescent cells, FOXO4 binds p53 and traps p53 inside the nucleus, preventing apoptosis and allowing damaged “zombie cells” to survive.
  • FOXO4-DRI breaks this complex, releasing p53 to translocate to mitochondria and trigger selective apoptosis in senescent cells.
  • Healthy normal cells are largely spared.
  • Reduces SASP (senescence-associated secretory phenotype), lowering chronic inflammation driven by senescent cells.

Research Areas

  • Senolytic research, selective clearance of senescent cells
  • Aging, frailty and age-related tissue degeneration animal models
  • Chronic inflammation & SASP signaling
  • Renal aging, cartilage degeneration, reproductive tissue aging
  • FOXO transcription factor and p53 protein-protein interaction study
  • Preclinical research for age-associated diseases
Specifications

10mg

评价

目前还没有评价

成为第一个“FOXO4” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注